Search details
1.
The Polypharmacological Effects of Cannabidiol.
Molecules
; 28(7)2023 Apr 06.
Article
in English
| MEDLINE | ID: mdl-37050032
2.
Mast Cells Localize in Hypoxic Zones of Tumors and Secrete CCL-2 under Hypoxia through Activation of L-Type Calcium Channels.
J Immunol
; 204(4): 1056-1068, 2020 02 15.
Article
in English
| MEDLINE | ID: mdl-31900336
3.
Protein Tyrosine Kinase Fyn Regulates TLR4-Elicited Responses on Mast Cells Controlling the Function of a PP2A-PKCα/ß Signaling Node Leading to TNF Secretion.
J Immunol
; 196(12): 5075-88, 2016 06 15.
Article
in English
| MEDLINE | ID: mdl-27183589
4.
Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom.
BMC Health Serv Res
; 18(1): 518, 2018 07 03.
Article
in English
| MEDLINE | ID: mdl-29970078
5.
Chemoinformatic Analysis of Selected Cacalolides from Psacalium decompositum (A. Gray) H. Rob. & Brettell and Psacalium peltatum (Kunth) Cass. and Their Effects on FcεRI-Dependent Degranulation in Mast Cells.
Molecules
; 23(12)2018 12 19.
Article
in English
| MEDLINE | ID: mdl-30572603
6.
Mexican Propolis: A Source of Antioxidants and Anti-Inflammatory Compounds, and Isolation of a Novel Chalcone and ε-Caprolactone Derivative.
Molecules
; 23(2)2018 Feb 06.
Article
in English
| MEDLINE | ID: mdl-29415430
7.
Small-Group Randomized Controlled Trial to Increase Condom Use and HIV Testing Among Hispanic/Latino Gay, Bisexual, and Other Men Who Have Sex With Men.
Am J Public Health
; 107(6): 969-976, 2017 06.
Article
in English
| MEDLINE | ID: mdl-28426301
8.
Healthcare resource use and costs associated with renal impairment in US patients with bone metastases from solid tumors.
J Oncol Pharm Pract
; 23(3): 195-202, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-26864940
9.
Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer.
Support Care Cancer
; 24(8): 3557-65, 2016 08.
Article
in English
| MEDLINE | ID: mdl-27022965
10.
Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Support Care Cancer
; 24(1): 447-455, 2016 Jan.
Article
in English
| MEDLINE | ID: mdl-26335402
11.
Physicians' preferences for bone metastases drug therapy in the United States.
Value Health
; 18(1): 78-83, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-25595237
12.
Measurement of skeletal related events in SEER-Medicare: a comparison of claims-based methods.
BMC Med Res Methodol
; 15: 65, 2015 Aug 19.
Article
in English
| MEDLINE | ID: mdl-26286392
13.
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom.
Support Care Cancer
; 23(1): 21-8, 2015 Jan.
Article
in English
| MEDLINE | ID: mdl-24939674
14.
Patient preferences for treatments to delay bone metastases.
Prostate
; 74(15): 1488-97, 2014 Nov.
Article
in English
| MEDLINE | ID: mdl-25132622
15.
Patients with bone metastases from solid tumors initiating treatment with a bone-targeted agent in 2011: a descriptive analysis using oncology clinic data in the US.
Support Care Cancer
; 22(10): 2697-705, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24789499
16.
Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones.
ACS Med Chem Lett
; 15(5): 610-618, 2024 May 09.
Article
in English
| MEDLINE | ID: mdl-38746894
17.
Drugs and natural products for the treatment of COVID-19 during 2020, the first year of the pandemic.
Bol Med Hosp Infant Mex
; 81(1): 53-72, 2024.
Article
in English
| MEDLINE | ID: mdl-38503318
18.
Cost-effectiveness of proprotein convertase subtilisin/kexin type 9 inhibition with evolocumab in patients with a history of myocardial infarction in Sweden.
Eur Heart J Qual Care Clin Outcomes
; 8(1): 31-38, 2022 01 05.
Article
in English
| MEDLINE | ID: mdl-33063111
19.
Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein.
Pharmacol Rep
; 74(6): 1315-1325, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35930194
20.
Erratum to: Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer.
Support Care Cancer
; 24(1): 457-458, 2016 01.
Article
in English
| MEDLINE | ID: mdl-26482379